American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 29, Issue 2 , Pages 113-118 , March 2008

Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?

  • Nathan W. Hales, MD
    • ,
  • Greg A. Krempl, MD
    • ,
  • Jesus E. Medina, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Otorhinolaryngology, University of Oklahoma Health Sciences Center, PO Box 26901 WP 1290, Oklahoma City, OK 73190, USA. Tel.: +1 405 271 5504; fax: +1 405 271 3248.

Received 20 January 2008

References 

  1. Alexander EK, Heering JP, Benson CB, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002;87(11):4924–4927
  2. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130:941–946
  3. Jana S, Abdel-Dayem HM, Young I. Nuclear medicine and thyroid cancer. Eur J Nucl Med. 1999;26:1528–1532
  4. Mazzaferi EL. Radioiodine and other treatments and outcomes. In:  Braverman LE,  Utiger RD editor. Werner and Ingbar's the thyroid: a fundamental and clinical text. 7th ed.. Philadelphia: JB Lippencott-Raven; 1996;p. 922–943
  5. Lind P. Multi-tracer imaging of thyroid nodules: is there a role in the preoperative assessment of nodular goiter?. Eur J Nucl Med. 1999;26:795–797
  6. Miller B, Burkey S, Lindberg G, et al. Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg. 2004;188(5):459–462
  7. Sclabas GM, Staerkel GA, Shapiro SE. Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg. 2003;186:702–710
  8. Goldstein RE, Netterville JL, Burkey B, et al. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg. 2002;235:656–664
  9. Tyler DS, Winchester DJ, Caraway NP. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery. 1994;116:1054–1060
  10. Bozbora A, Erbil Y, Ozarmagan S, et al. Color Doppler sonography in cold thyroid nodules for malignancy prediction. Acta Chir Belg. 2002;102(4):259–262
  11. Welker MJ, Orlov D. Thyroid nodules. Am Fam Physician. 2003;67(3):559–566
  12. Galloway RJ, Smallridge RC. Imaging in thyroid cancer. Endocrinol Metab Clin North Am. 1996;25:93–111
  13. Gordon BA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls and technical considerations. Am J Radiol. 1997;169:1675–1680
  14. Ghassan EH, Abass A, Ayse M, Gonca B, Hongming Z. Normal variants in [18F]-fluorodeoxyglucose PET imaging. Radiol Clin North Am. 2004;42(6):
  15. Haber RS, Weiser KR, Pritsker A, et al. GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid. 1997;7:363–367
  16. Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab. 2002;87(4):1517–1520
  17. Ramos CD, Chisin R, Yeung HWD, et al. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med. 2001;26:193–197
  18. Feine U, Lietzenmayer R, Hanke JP, et al. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med. 1996;37:1468–1472
  19. Grunwald F, Kalicke T, Feine U, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med. 1999;26:1547–1552
  20. Uematsu H, Sadato N, Ohtsubo T, et al. Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med. 1998;39(3):453–459
  21. Zhuang H, Kumar R, Mandel S, et al. Investigation of thyroid, head, and neck cancers with PET. Radiol Clin North Am. 2004;42(6):1101–1111
  22. Wang W, Larson SM, Fazzari M, et al. Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab. 2000;85:1107–1113
  23. Musholt TJ, Musholt PB, Dehdashti F, et al. Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study. Surgery. 1997;122:1049–1061
  24. Stokkel MPM, Moons KGM, ten Broek F-W, et al. 18F-Fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer. 1999;86:2370–2377
  25. Wiesner W, Engel H, von Schulthess GK, et al. FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive Hürthle cell tumor of the thyroid. Radiology. 1999;9:975–978
  26. Davis P, Perrier N, Adler L, et al. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg. 2001;67:582–584
  27. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by F-18-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab. 2003;88:4100–4104

☆ Oral presentation, American Head and Neck Society, 2006 Annual Meeting & Research Workshop on Biology, Prevention and Treatment of Head and Neck Cancer, Chicago, IL, August 19, 2006.☆This project was supported by the Resident Research Fund of The University of Oklahoma Health Sciences Center, Department of Otorhinolaryngology, and by PET Imaging of Oklahoma (Oklahoma City, OK).

PII: S0196-0709(07)00048-8

doi: 10.1016/j.amjoto.2007.04.006

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 29, Issue 2 , Pages 113-118 , March 2008

Article Tools